Guest guest Posted March 31, 2011 Report Share Posted March 31, 2011 News 9 new results for Hepatitis 3-Drug Combo May Treat Hepatitis C WebMD By Salynn Boyles March 30, 2011 -- Two highly anticipated hepatitis C drugs are poised to usher in a new era in the treatment of the viral disease as early as this summer, experts say. The Merck drug boceprevir and Vertex Pharmaceutical's similar drug ... See all stories on this topic » Achillion hepatitis drug shows promise in mid-stage trial Reuters March 30 (Reuters) - Achillion Pharmaceuticals Inc said its experimental lead drug to treat chronic hepatitis C infection showed strong antiviral activity in a mid-stage trial, sending its shares up 4 percent in pre-market trade. ... See all stories on this topic » 2 hepatitis C treatments point to a cure Detroit Free Press 5:38 pm By PATRICIA ANSTETT The 170000 Americans newly diagnosed each year with hepatitis C soon are expected to have two new drug-treatment options that promise a possible cure from the liver disease. Both Merck & Co. of Whitehouse Station, ... See all stories on this topic » Achillion Reports Positive Results For Hepatitis C Treatment Wall Street Journal Shares of Achillion Pharmaceuticals Inc. (ACHN) rose 6.4% to $7.50 in recent premarket trading Wednesday after the drug company reported positive results for its experimental treatment of chronic hepatitis C. Top-line results of a phase 2a clinical ... See all stories on this topic » Helping an alcoholic who won't help herself Boston Globe Q. My mom is 50 years old and just told me that she has hepatitis C. I think she has probably had it for quite some time, since my late father also had it. The problem is, Mom is an alcoholic and has no interest in giving up booze. I know all about AA, ... See all stories on this topic » The duck hepatitis virus 5'-UTR possesses HCV-like IRES activity that is ... 7thSpace Interactive (press release) Duck hepatitis virus (DHV-1) is a worldwide distributed picornavirus that causes acute and fatal disease in young ducklings. Recently, the complete genome of DHV-1 has been determined and comparative sequence analysis has shown that possesses the ... See all stories on this topic » Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b ... istockAnalyst.com (press release) 30, 2011 (Business Wire) -- Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C. The PPI-461 phase 1b ... See all stories on this topic » Could HIV-infected organs save lives? EurekAlert (press release) Segev suggests that, in transitioning to a system where HIV-infected donor organs can be transplanted into HIV-infected patients, doctors can call on the lessons and experience of transplanting hepatitis C patients with organs from people with the same ... See all stories on this topic » Judge tosses doctor's lawsuit against state medical board Las Vegas Sun Buckwalter complained the board has failed to detail the allegations against him or schedule a hearing so he can defend himself and that it bowed to political pressure resulting from the hepatitis C crisis in Las Vegas in 2008. ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 31, 2011 Report Share Posted March 31, 2011 News 9 new results for Hepatitis 3-Drug Combo May Treat Hepatitis C WebMD By Salynn Boyles March 30, 2011 -- Two highly anticipated hepatitis C drugs are poised to usher in a new era in the treatment of the viral disease as early as this summer, experts say. The Merck drug boceprevir and Vertex Pharmaceutical's similar drug ... See all stories on this topic » Achillion hepatitis drug shows promise in mid-stage trial Reuters March 30 (Reuters) - Achillion Pharmaceuticals Inc said its experimental lead drug to treat chronic hepatitis C infection showed strong antiviral activity in a mid-stage trial, sending its shares up 4 percent in pre-market trade. ... See all stories on this topic » 2 hepatitis C treatments point to a cure Detroit Free Press 5:38 pm By PATRICIA ANSTETT The 170000 Americans newly diagnosed each year with hepatitis C soon are expected to have two new drug-treatment options that promise a possible cure from the liver disease. Both Merck & Co. of Whitehouse Station, ... See all stories on this topic » Achillion Reports Positive Results For Hepatitis C Treatment Wall Street Journal Shares of Achillion Pharmaceuticals Inc. (ACHN) rose 6.4% to $7.50 in recent premarket trading Wednesday after the drug company reported positive results for its experimental treatment of chronic hepatitis C. Top-line results of a phase 2a clinical ... See all stories on this topic » Helping an alcoholic who won't help herself Boston Globe Q. My mom is 50 years old and just told me that she has hepatitis C. I think she has probably had it for quite some time, since my late father also had it. The problem is, Mom is an alcoholic and has no interest in giving up booze. I know all about AA, ... See all stories on this topic » The duck hepatitis virus 5'-UTR possesses HCV-like IRES activity that is ... 7thSpace Interactive (press release) Duck hepatitis virus (DHV-1) is a worldwide distributed picornavirus that causes acute and fatal disease in young ducklings. Recently, the complete genome of DHV-1 has been determined and comparative sequence analysis has shown that possesses the ... See all stories on this topic » Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b ... istockAnalyst.com (press release) 30, 2011 (Business Wire) -- Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C. The PPI-461 phase 1b ... See all stories on this topic » Could HIV-infected organs save lives? EurekAlert (press release) Segev suggests that, in transitioning to a system where HIV-infected donor organs can be transplanted into HIV-infected patients, doctors can call on the lessons and experience of transplanting hepatitis C patients with organs from people with the same ... See all stories on this topic » Judge tosses doctor's lawsuit against state medical board Las Vegas Sun Buckwalter complained the board has failed to detail the allegations against him or schedule a hearing so he can defend himself and that it bowed to political pressure resulting from the hepatitis C crisis in Las Vegas in 2008. ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.